KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Times Interest Earned (2016 - 2025)

Pacira BioSciences has reported Times Interest Earned over the past 16 years, most recently at $0.6 for Q4 2025.

  • Quarterly results put Times Interest Earned at $0.6 for Q4 2025, down 88.61% from a year ago — trailing twelve months through Dec 2025 was $1.1 (up 124.84% YoY), and the annual figure for FY2025 was $1.1, up 124.84%.
  • Times Interest Earned for Q4 2025 was $0.6 at Pacira BioSciences, down from $1.49 in the prior quarter.
  • Over the last five years, Times Interest Earned for PCRX hit a ceiling of $10.32 in Q2 2023 and a floor of -$29.76 in Q3 2024.
  • Median Times Interest Earned over the past 5 years was $2.47 (2022), compared with a mean of $1.75.
  • Peak annual rise in Times Interest Earned hit 1336.03% in 2024, while the deepest fall reached 681.66% in 2024.
  • Pacira BioSciences' Times Interest Earned stood at $0.4 in 2021, then tumbled by 321.78% to -$0.9 in 2022, then skyrocketed by 1192.59% to $9.79 in 2023, then crashed by 46.08% to $5.28 in 2024, then plummeted by 88.61% to $0.6 in 2025.
  • The last three reported values for Times Interest Earned were $0.6 (Q4 2025), $1.49 (Q3 2025), and $1.81 (Q2 2025) per Business Quant data.